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Abstract
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Creative  Commons  Attribution  License,  which  permits  unrestricted  use,  distribution,  and
reproduction in any medium, provided the original author and source are credited.Objective and
Methods This study investigated the potential for protective effects of human umbilical cord
blood mononuclear cells (UCB-MCs) genetically modified with the VEGF and GNDF genes on
contusion spinal cord injury (SCI) in rats. An adenoviral vector was constructed for targeted
delivery of VEGF and GDNF to UCB-MCs. Using a rat contusion SCI model we examined the
efficacy of the construct on tissue sparing, glial scar severity, the extent of axonal regeneration,
recovery of motor function, and analyzed the expression of the recombinant genes VEGF and
GNDF in vitro and in vivo.  Results Transplantation of  UCB-MCs transduced with adenoviral
vectors  expressing  VEGF  and  GDNF at  the  site  of  SCI  induced  tissue  sparing,  behavioral
recovery and axonal regeneration comparing to the other constructs tested. The adenovirus
encoding VEGF and GDNF for transduction of UCB-MCs was shown to be an effective and stable
vehicle  for  these cells  in  vivo following the transplantation into  the contused spinal  cord.
Conclusion Our results show that a gene delivery using UCB-MCs-expressing VEGF and GNDF
genes improved both structural and functional parameters after SCI. Further histological and
behavioral studies, especially at later time points, in animals with SCI after transplantation of
genetically modified UCB-MCs (overexpressing VEGF and GDNF genes) will provide additional
insight into therapeutic potential of such cells.
http://dx.doi.org/10.1371/journal.pone.0151745
